HOME >> BIOLOGY >> NEWS
Michael R. Zalutsky receives SNM's 2007 Paul C. Aebersold Award

WASHINGTON, D.C. -- Michael R. Zalutsky, a professor of radiology and biomedical engineering at Duke University in Durham, N.C., received the 2007 Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science from SNM, the largest international society for molecular imaging and nuclear medicine professionals. SNM is holding its 54th Annual Meeting in Washington, D.C.

"With this award, the molecular imaging and nuclear medicine community recognizes Dr. Zalutskys intellectual capital, national reputation and prominent role in advancing significant contributions to medical scienceespecially in using molecular targeting to combat cancer," said SNM President Martin P. Sandler. "He has made many contributions to both the basic and applied aspects of molecular therapy and nuclear medicine in a variety of areas, including radionuclide production, radiochemistry and radiation biology," added Sandler.

"Only a small group of highly distinguished researchers have received the Aebersold Award for outstanding achievement in basic science applied to nuclear medicine. Dr. Zalutskys contributions highly qualify to place him in that group of individuals," said Mathew L. Thakur, chair of SNMs Committee on Awards and an Aebersold recipient. Zalutsky received the award, named for Paul C. Aebersold, a pioneer in the biologic and medical application of radioactive materials and the first director of the Atomic Energy Commissions Division of Isotope Development, at the meetings June opening session. Thakur indicated that Zalutskys research has had a significant impact on the concepts and methods that drive the field of therapeutic nuclear medicine, showing how technologies and approaches from the domain of nuclear medicine can have an impact on other disciplines.

Among Zalutskys many accomplishments include his outstanding contributions in developing improved methods for the radiohalogenation of monoclonal antibodies and peptides; i
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
3-Jun-2007


Page: 1 2 3 4

Related biology news :

1. Dr. Michael Petrides: Elected to the American Academy of Arts and Sciences
2. SIAMs Julian Cole Lectureship awarded to Dr. Michael J. Shelley of the Courant Institute
3. HHS Secretary Michael O. Leavitt to speak at international HapMap press conference
4. Michael R. Zalutsky named recipient of Society of Nuclear Medicines 2005 Berson-Yalow Award
5. Michael F. Hochella Jr. named Virginias 2005 Outstanding Scientist
6. Rob DeSalle and Michael Yudell to appear at the American Museum of Natural History
7. Carnegie Mellons Peter Adams receives EPA research grant
8. Philadelphia ecologist receives top Mongolia honor
9. VIB scientist receives major research grant
10. Maynard Olson receives $500,000 Gruber Genetics Prize
11. University of Cincinnati receives $1.7M to research molecular treatment of brain injury

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
Breaking Biology Technology:
Cached News: